Similar articles

• Abecarnil is a full agonist at some, and a partial agonist at other recombinant GABAA receptor subtypes.

  Pribilla I, Neuhaus R, Huba R, Hillmann M, Turner JD, Stephens DN, Schneider HH. Pribilla I, et al. Psychopharmacol Ser. 1993;11:50-61. doi: 10.1007/978-3-642-78451-4_5. Psychopharmacol Ser. 1993. PMID: 7908433 Review. No abstract available.
• Pharmacological evidence for full agonist activity of abecarnil at certain GABAA receptors.

  Serra M, Ghiani CA, Motzo C, Biggio G. Serra M, et al. Psychopharmacol Ser. 1993;11:62-78. doi: 10.1007/978-3-642-78451-4_6. Psychopharmacol Ser. 1993. PMID: 7908434 Review. No abstract available.
• Pharmacokinetics, anticonvulsant efficacy and adverse effects of the beta-carboline abecarnil, a novel ligand for benzodiazepine receptors, after acute and chronic administration in dogs.

  Löscher W, Hönack D, Scherkl R, Hashem A, Frey HH. Löscher W, et al. J Pharmacol Exp Ther. 1990 Nov;255(2):541-8. J Pharmacol Exp Ther. 1990. PMID: 1978730
• Pharmacological characterization of the novel anxiolytic beta-carboline abecarnil in rodents and primates.

  Ozawa M, Nakada Y, Sugimachi K, Yabuuchi F, Akai T, Mizuta E, Kuno S, Yamaguchi M. Ozawa M, et al. Jpn J Pharmacol. 1994 Mar;64(3):179-87. doi: 10.1254/jjp.64.179. Jpn J Pharmacol. 1994. PMID: 7912751
• Abecarnil, a metabolically stable, anxioselective beta-carboline acting at benzodiazepine receptors.

  Stephens DN, Schneider HH, Kehr W, Andrews JS, Rettig KJ, Turski L, Schmiechen R, Turner JD, Jensen LH, Petersen EN, et al. Stephens DN, et al. J Pharmacol Exp Ther. 1990 Apr;253(1):334-43. J Pharmacol Exp Ther. 1990. PMID: 1970361